5 Biotech Stocks Ready To Resume Their Rally

T. Rowe Price's Ziad Bakri doesn't know when the sector will recover, but he's confident in these drug makers.

Correction: An earlier version of this story misstated the return of the biotech index. The return was for calendar years 2012 and 2013.

While U.S. stocks have done well in recent years, the performance of biotechnology companies has been off the charts. The Nasdaq biotech index nearly quintupled off its 2009 low, soaring nearly 120% from the beginning of 2012 to the end of last year. All such runs stall eventually, and 2014 has...